Oncorhynchus tshawytscha isolate Ot180627B linkage group LG34, Otsh_v2.0, whole genome shotgun sequence.
Oncorhynchus tshawytscha (Chinook salmon)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Actinopterygii; Neopterygii; Teleostei; Protacanthopterygii; Salmoniformes; Salmonidae; Salmoninae; Oncorhynchus.
Chinook salmon (Oncorhynchus tshawytscha) genome and transcriptome
REFSEQ INFORMATION: The reference sequence is identical to\nCM031232.1.\nAssembly name: Otsh_v2.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Fisheries and Oceans Canada\non 2021/05/07. The original whole-genome shotgun project has the\naccession JAEPEU000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Fisheries and Oceans Canada\nAssembly Date :: NOV-2020\nAssembly Method :: Flye v. 2.6-g6f887ae; Racon v. 1.4.16;\n Pilon v. 1.22; Pilon v. 1.22; Chromonomer\n v. 1.10; Ragtag v. 1.0.1; Custom v. 1.0\nAssembly Name :: Otsh_v2.0\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 130.0x\nSequencing Technology :: Oxford Nanopore MinION; PacBio Sequel\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Oncorhynchus tshawytscha Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Canada: British Columbia, Capilano River
Derived by automated computational analysis using gene prediction method: Gnomon.
centrobin, centrosomal BRCA2 interacting protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
dnaJ homolog subfamily A member 1, transcript variant X3
dnaJ homolog subfamily A member 1, transcript variant X1
dnaJ homolog subfamily A member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
microsomal triglyceride transfer protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain-containing protein 149, transcript variant X1
coiled-coil domain-containing protein 149, transcript variant X4
coiled-coil domain-containing protein 149, transcript variant X2
coiled-coil domain-containing protein 149, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
coiled-coil domain-containing protein 149 isoform X1
coiled-coil domain-containing protein 149 isoform X2
coiled-coil domain-containing protein 149 isoform X4
coiled-coil domain-containing protein 149 isoform X3
extracellular superoxide dismutase [Cu-Zn]
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15
caspase 3, apoptosis-related cysteine peptidase a
primase and polymerase (DNA-directed), transcript variant X3
primase and polymerase (DNA-directed), transcript variant X1
primase and polymerase (DNA-directed), transcript variant X2
DNA-directed primase/polymerase protein isoform X1
DNA-directed primase/polymerase protein isoform X2
acyl-CoA synthetase long chain family member 1a, transcript variant X1
acyl-CoA synthetase long chain family member 1a, transcript variant X2
long-chain-fatty-acid--CoA ligase 1a isoform X1
long-chain-fatty-acid--CoA ligase 1a isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hairy and enhancer of split-related protein helt
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein si:ch211-197n1.2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia and flagella associated protein 97, transcript variant X3
cilia and flagella associated protein 97, transcript variant X1
cilia and flagella associated protein 97, transcript variant X2
cilia- and flagella-associated protein 97 isoform X2
cilia- and flagella-associated protein 97 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ankyrin repeat domain-containing protein 37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
microtubule-associated protein 9, transcript variant X2
microtubule-associated protein 9, transcript variant X1
guanylate cyclase 1 soluble subunit alpha 1, transcript variant X2
guanylate cyclase 1 soluble subunit alpha 1, transcript variant X1
guanylate cyclase soluble subunit alpha-1 isoform X1
guanylate cyclase soluble subunit alpha-1 isoform X2
guanylate cyclase 1 soluble subunit beta 1
guanylate cyclase soluble subunit beta-1
fatty acid binding protein 2, intestinal
ubiquitin specific peptidase 53b, transcript variant X2
ubiquitin specific peptidase 53b, transcript variant X1
inactive ubiquitin carboxyl-terminal hydrolase 53 isoform X2
inactive ubiquitin carboxyl-terminal hydrolase 53 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
AT-rich interactive domain-containing protein 1A-like
gamma-gliadin-like, transcript variant X3
gamma-gliadin-like, transcript variant X2
gamma-gliadin-like, transcript variant X1
secretory calcium-binding phosphoprotein 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
late cornified envelope-like proline-rich protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
proline-rich protein HaeIII subfamily 1-like
odontogenic, ameloblast associated, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
odontogenic, ameloblast associated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
odontogenic, ameloblast associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
RNA polymerase II degradation factor 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC121841813, transcript variant X2
uncharacterized LOC121841813, transcript variant X4
uncharacterized LOC121841813, transcript variant X3
uncharacterized LOC121841813, transcript variant X1
uncharacterized protein LOC121841813 isoform X2
uncharacterized protein LOC121841813 isoform X3
uncharacterized protein LOC121841813 isoform X1
glycoprotein hormones alpha chain 2-like
secretory calcium-binding phosphoprotein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
secretory calcium-binding phosphoprotein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
secretory calcium-binding phosphoprotein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
secretory calcium-binding phosphoprotein 1 isoform X1
secretory calcium-binding phosphoprotein 1 isoform X2
secretory calcium-binding phosphoprotein 1 isoform X3
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
TNFAIP3-interacting protein 2, transcript variant X2
TNFAIP3-interacting protein 2, transcript variant X1
TNFAIP3-interacting protein 2 isoform X1
TNFAIP3-interacting protein 2 isoform X2
family with sequence similarity 193 member A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
ADP-ribosylation factor interacting protein 1 (arfaptin 1), transcript variant X1
ADP-ribosylation factor interacting protein 1 (arfaptin 1), transcript variant X2
ADP-ribosylation factor interacting protein 1 (arfaptin 1), transcript variant X4
ADP-ribosylation factor interacting protein 1 (arfaptin 1), transcript variant X5
ADP-ribosylation factor interacting protein 1 (arfaptin 1), transcript variant X3
tripartite motif containing 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
tripartite motif containing 2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
tripartite motif containing 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tripartite motif containing 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
tripartite motif-containing protein 2 isoform X1
tripartite motif-containing protein 2 isoform X2
meiotic nuclear divisions 1 homolog (S. cerevisiae)
meiotic nuclear division protein 1 homolog
transmembrane 131 like, transcript variant X1
transmembrane 131 like, transcript variant X3
transmembrane 131 like, transcript variant X5
transmembrane 131 like, transcript variant X4
transmembrane 131 like, transcript variant X2
transmembrane protein 131-like isoform X1
transmembrane protein 131-like isoform X3
transmembrane protein 131-like isoform X5
transmembrane protein 131-like isoform X2
transmembrane protein 131-like isoform X4
secreted frizzled-related protein 2-like
dachsous cadherin-related 2, transcript variant X1
dachsous cadherin-related 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cyclic nucleotide gated channel subunit alpha 1a
sodium/hydrogen exchanger 9B2, transcript variant X1
sodium/hydrogen exchanger 9B2, transcript variant X2
CDGSH iron-sulfur domain-containing protein 2A
succinate-CoA ligase GDP/ADP-forming subunit alph
succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial
catenin (cadherin-associated protein), alpha 2
leucine-rich repeat transmembrane neuronal protein 1
C-type lectin domain family 4 member E, transcript variant X1
C-type lectin domain family 4 member E, transcript variant X2
C-type lectin domain family 4 member E isoform X1
C-type lectin domain family 4 member E isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
RING finger protein 24, transcript variant X2
RING finger protein 24, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mannosyl-oligosaccharide glucosidase, transcript variant X3
mannosyl-oligosaccharide glucosidase, transcript variant X1
mannosyl-oligosaccharide glucosidase, transcript variant X2
mannosyl-oligosaccharide glucosidase, transcript variant X5
mannosyl-oligosaccharide glucosidase, transcript variant X6
mannosyl-oligosaccharide glucosidase, transcript variant X7
mannosyl-oligosaccharide glucosidase, transcript variant X4
mannosyl-oligosaccharide glucosidase isoform X2
mannosyl-oligosaccharide glucosidase isoform X1
mannosyl-oligosaccharide glucosidase isoform X3
mannosyl-oligosaccharide glucosidase isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
C-type lectin domain family 4 member E-like, transcript variant X2
C-type lectin domain family 4 member E-like, transcript variant X3
C-type lectin domain family 4 member E-like, transcript variant X1
C-type lectin domain family 4 member E-like isoform X1
C-type lectin domain family 4 member E-like isoform X2
ecto-ADP-ribosyltransferase 4, transcript variant X1
ecto-ADP-ribosyltransferase 4, transcript variant X2
ecto-ADP-ribosyltransferase 4 isoform X1
ecto-ADP-ribosyltransferase 4 isoform X2
NLR family CARD domain-containing protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
NLR family CARD domain-containing protein 3, transcript variant X3
NLR family CARD domain-containing protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
NLR family CARD domain-containing protein 3
SLAM family member 5, transcript variant X1
SLAM family member 5, transcript variant X2
SLAM family member 5, transcript variant X3
SLAM family member 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
T-cell surface antigen CD2-like, transcript variant X4
T-cell surface antigen CD2-like, transcript variant X1
T-cell surface antigen CD2-like, transcript variant X3
T-cell surface antigen CD2-like, transcript variant X2
T-cell surface antigen CD2-like, transcript variant X5
T-cell surface antigen CD2-like isoform X3
uncharacterized protein LOC112231737 isoform X1
uncharacterized protein LOC112231737 isoform X2
uncharacterized protein LOC112231737 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
hepatocyte cell adhesion molecule isoform X1
hepatocyte cell adhesion molecule, transcript variant X2
hepatocyte cell adhesion molecule, transcript variant X1
uncharacterized protein LOC112231746 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
leucine-rich repeats and immunoglobulin-like domains protein 1 isoform X1
hepatocyte cell adhesion molecule isoform X2
leucine-rich repeats and immunoglobulin-like domains protein 1
uncharacterized LOC112231767, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC112231767, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
T-cell surface antigen CD2, transcript variant X3
T-cell surface antigen CD2, transcript variant X4
T-cell surface antigen CD2, transcript variant X1
T-cell surface antigen CD2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ribosomal protein S6 kinase beta-2, transcript variant X4
ribosomal protein S6 kinase beta-2, transcript variant X1
ribosomal protein S6 kinase beta-2, transcript variant X2
ribosomal protein S6 kinase beta-2, transcript variant X3
ribosomal protein S6 kinase beta-2 isoform X3
ribosomal protein S6 kinase beta-2 isoform X1
ribosomal protein S6 kinase beta-2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
LON peptidase N-terminal domain and ring finger 1, like
LON peptidase N-terminal domain and RING finger protein 1
calcium-binding protein 2-like, transcript variant X2
calcium-binding protein 2-like, transcript variant X1
calcium-binding protein 2-like, transcript variant X3
double C2-like domain-containing protein beta
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: double C2-like domain-containing protein beta
transmembrane protein 134, transcript variant X2
transmembrane protein 134, transcript variant X1
AH receptor-interacting protein, transcript variant X2
AH receptor-interacting protein, transcript variant X1
cyclin-dependent kinase 2-associated protein 2, transcript variant X2
cyclin-dependent kinase 2-associated protein 2, transcript variant X1
cyclin-dependent kinase 2-associated protein 2 isoform X1
cyclin-dependent kinase 2-associated protein 2 isoform X2
butyrophilin subfamily 3 member A1, transcript variant X2
butyrophilin subfamily 3 member A1, transcript variant X43
butyrophilin subfamily 3 member A1, transcript variant X18
butyrophilin subfamily 3 member A1, transcript variant X25
butyrophilin subfamily 3 member A1, transcript variant X35
butyrophilin subfamily 3 member A1, transcript variant X30
butyrophilin subfamily 3 member A1, transcript variant X41
butyrophilin subfamily 3 member A1, transcript variant X7
butyrophilin subfamily 3 member A1, transcript variant X10
butyrophilin subfamily 3 member A1, transcript variant X8
butyrophilin subfamily 3 member A1, transcript variant X13
butyrophilin subfamily 3 member A1, transcript variant X5
butyrophilin subfamily 3 member A1, transcript variant X24
butyrophilin subfamily 3 member A1, transcript variant X29
butyrophilin subfamily 3 member A1, transcript variant X6
butyrophilin subfamily 3 member A1, transcript variant X16
butyrophilin subfamily 3 member A1, transcript variant X45
butyrophilin subfamily 3 member A1, transcript variant X46
butyrophilin subfamily 3 member A1, transcript variant X12
butyrophilin subfamily 3 member A1, transcript variant X49
butyrophilin subfamily 3 member A1, transcript variant X11
butyrophilin subfamily 3 member A1, transcript variant X23
butyrophilin subfamily 3 member A1, transcript variant X22
butyrophilin subfamily 3 member A1, transcript variant X38
butyrophilin subfamily 3 member A1, transcript variant X34
butyrophilin subfamily 3 member A1, transcript variant X44
butyrophilin subfamily 3 member A1, transcript variant X50
butyrophilin subfamily 3 member A1, transcript variant X47
butyrophilin subfamily 3 member A1, transcript variant X15
butyrophilin subfamily 3 member A1, transcript variant X21
butyrophilin subfamily 3 member A1, transcript variant X36
butyrophilin subfamily 3 member A1, transcript variant X14
butyrophilin subfamily 3 member A1, transcript variant X27
butyrophilin subfamily 3 member A1, transcript variant X3
butyrophilin subfamily 3 member A1, transcript variant X19
butyrophilin subfamily 3 member A1, transcript variant X31
butyrophilin subfamily 3 member A1, transcript variant X17
butyrophilin subfamily 3 member A1, transcript variant X28
butyrophilin subfamily 3 member A1, transcript variant X26
butyrophilin subfamily 3 member A1, transcript variant X4
butyrophilin subfamily 3 member A1, transcript variant X1
butyrophilin subfamily 3 member A1, transcript variant X33
butyrophilin subfamily 3 member A1, transcript variant X40
butyrophilin subfamily 3 member A1, transcript variant X9
butyrophilin subfamily 3 member A1, transcript variant X20
butyrophilin subfamily 3 member A1, transcript variant X37
butyrophilin subfamily 3 member A1, transcript variant X39
butyrophilin subfamily 3 member A1, transcript variant X42
butyrophilin subfamily 3 member A1, transcript variant X48
butyrophilin subfamily 3 member A1, transcript variant X32
uncharacterized protein LOC112231763 isoform X1
butyrophilin subfamily 3 member A3 isoform X6
uncharacterized protein LOC112231763 isoform X9
uncharacterized protein LOC112231763 isoform X17
uncharacterized protein LOC112231763 isoform X7
uncharacterized protein LOC112231763 isoform X12
uncharacterized protein LOC112231763 isoform X24
uncharacterized protein LOC112231763 isoform X34
uncharacterized protein LOC112231763 isoform X4
uncharacterized protein LOC112231763 isoform X29
uncharacterized protein LOC112231763 isoform X23
uncharacterized protein LOC112231763 isoform X28
uncharacterized protein LOC112231763 isoform X32
uncharacterized protein LOC112231763 isoform X40
uncharacterized protein LOC112231763 isoform X39
uncharacterized protein LOC112231763 isoform X8
uncharacterized protein LOC112231763 isoform X19
uncharacterized protein LOC112231763 isoform X5
uncharacterized protein LOC112231763 isoform X15
uncharacterized protein LOC112231763 isoform X36
putative butyrophilin subfamily 2 member A3 isoform X44
putative butyrophilin subfamily 2 member A3 isoform X45
uncharacterized protein LOC112231763 isoform X11
butyrophilin subfamily 3 member A1 isoform X48
uncharacterized protein LOC112231763 isoform X10
uncharacterized protein LOC112231763 isoform X22
uncharacterized protein LOC112231763 isoform X21
uncharacterized protein LOC112231763 isoform X37
uncharacterized protein LOC112231763 isoform X33
putative butyrophilin subfamily 2 member A3 isoform X43
butyrophilin subfamily 3 member A1 isoform X49
E3 ubiquitin/ISG15 ligase TRIM25 isoform X38
uncharacterized protein LOC112231763 isoform X41
putative butyrophilin subfamily 2 member A3 isoform X46
putative butyrophilin subfamily 2 member A3 isoform X47
uncharacterized protein LOC112231763 isoform X14
uncharacterized protein LOC112231763 isoform X20
E3 ubiquitin/ISG15 ligase TRIM25 isoform X35
uncharacterized protein LOC112231763 isoform X13
uncharacterized protein LOC112231763 isoform X26
uncharacterized protein LOC112231763 isoform X2
uncharacterized protein LOC112231763 isoform X18
uncharacterized protein LOC112231763 isoform X30
uncharacterized protein LOC112231763 isoform X16
butyrophilin subfamily 2 member A1 isoform X27
uncharacterized protein LOC112231763 isoform X25
uncharacterized protein LOC112231763 isoform X3
uncharacterized protein LOC112231763 isoform X31
E3 ubiquitin/ISG15 ligase TRIM25 isoform X42
butyrophilin subfamily 1 member A1, transcript variant X6
butyrophilin subfamily 1 member A1, transcript variant X2
butyrophilin subfamily 1 member A1, transcript variant X5
butyrophilin subfamily 1 member A1, transcript variant X1
butyrophilin subfamily 1 member A1, transcript variant X4
butyrophilin subfamily 2 member A1 isoform X1
butyrophilin subfamily 1 member A1 isoform X2
butyrophilin subfamily 1 member A1 isoform X4
butyrophilin subfamily 1 member A1 isoform X5
butyrophilin subfamily 1 member A1 isoform X6
butyrophilin subfamily 1 member A1, transcript variant X3
butyrophilin subfamily 2 member A1 isoform X3
erythroid membrane-associated protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ankyrin repeat domain 49, transcript variant X1
ankyrin repeat domain 49, transcript variant X2
ankyrin repeat domain-containing protein 49
uncharacterized LOC112231720, transcript variant X2
uncharacterized LOC112231720, transcript variant X3
uncharacterized LOC112231720, transcript variant X1
uncharacterized protein LOC112231720 isoform X2
uncharacterized protein LOC112231720 isoform X3
uncharacterized protein LOC112231720 isoform X1
uncharacterized LOC112231758, transcript variant X1
uncharacterized LOC112231758, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC112231758 isoform X1
uncharacterized protein LOC112231758 isoform X2
uncharacterized LOC121841777, transcript variant X2
uncharacterized LOC121841777, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
GATA zinc finger domain-containing protein 14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
claudin domain containing 1b, transcript variant X2
claudin domain containing 1b, transcript variant X3
claudin domain containing 1b, transcript variant X4
claudin domain containing 1b, transcript variant X1
claudin domain containing 1b, transcript variant X5
N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming) B, transcript variant X3
N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming) B, transcript variant X2
N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming) B, transcript variant X1
N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming) B
tachykinin receptor 3-like, transcript variant X1
tachykinin receptor 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
T-cell ecto-ADP-ribosyltransferase 1, transcript variant X3
T-cell ecto-ADP-ribosyltransferase 1, transcript variant X2
T-cell ecto-ADP-ribosyltransferase 1, transcript variant X1
probable E3 ubiquitin-protein ligase HERC3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
endonuclease domain-containing 1 protein
probable E3 ubiquitin-protein ligase HERC3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
coiled-coil domain-containing protein 86
oxysterol-binding protein 1, transcript variant X4
oxysterol-binding protein 1, transcript variant X2
oxysterol-binding protein 1, transcript variant X3
oxysterol-binding protein 1, transcript variant X5
oxysterol-binding protein 1, transcript variant X8
oxysterol-binding protein 1, transcript variant X7
oxysterol-binding protein 1, transcript variant X6
oxysterol-binding protein 1, transcript variant X1
pericentriolar material 1 protein-like, transcript variant X1
pericentriolar material 1 protein-like, transcript variant X5
pericentriolar material 1 protein-like, transcript variant X4
pericentriolar material 1 protein-like, transcript variant X3
pericentriolar material 1 protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
pericentriolar material 1 protein-like, transcript variant X2
pericentriolar material 1 protein-like isoform X1
pericentriolar material 1 protein-like isoform X4
pericentriolar material 1 protein-like isoform X3
pericentriolar material 1 protein-like isoform X2
pericentriolar material 1 protein-like isoform X5
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin Fat 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NACHT, LRR and PYD domains-containing protein 3-like
LOW QUALITY PROTEIN: NACHT, LRR and PYD domains-containing protein 3-like
sorbin and SH3 domain containing 2a, transcript variant X5
sorbin and SH3 domain containing 2a, transcript variant X4
sorbin and SH3 domain containing 2a, transcript variant X1
sorbin and SH3 domain containing 2a, transcript variant X6
sorbin and SH3 domain containing 2a, transcript variant X7
sorbin and SH3 domain containing 2a, transcript variant X12
sorbin and SH3 domain containing 2a, transcript variant X9
sorbin and SH3 domain containing 2a, transcript variant X18
sorbin and SH3 domain containing 2a, transcript variant X14
sorbin and SH3 domain containing 2a, transcript variant X16
sorbin and SH3 domain containing 2a, transcript variant X15
sorbin and SH3 domain containing 2a, transcript variant X17
sorbin and SH3 domain containing 2a, transcript variant X19
sorbin and SH3 domain containing 2a, transcript variant X2
sorbin and SH3 domain containing 2a, transcript variant X3
sorbin and SH3 domain containing 2a, transcript variant X8
sorbin and SH3 domain-containing protein 2 isoform X11
sorbin and SH3 domain-containing protein 2 isoform X16
sorbin and SH3 domain-containing protein 2 isoform X13
sorbin and SH3 domain-containing protein 2 isoform X12
sorbin and SH3 domain-containing protein 2 isoform X14
sorbin and SH3 domain-containing protein 2 isoform X15
sorbin and SH3 domain-containing protein 2 isoform X1
sorbin and SH3 domain-containing protein 2 isoform X4
sorbin and SH3 domain-containing protein 2 isoform X6
sorbin and SH3 domain-containing protein 2 isoform X3
sorbin and SH3 domain-containing protein 2 isoform X2
sorbin and SH3 domain-containing protein 2 isoform X9
sorbin and SH3 domain-containing protein 2 isoform X5
sorbin and SH3 domain containing 2a, transcript variant X13
sorbin and SH3 domain containing 2a, transcript variant X10
sorbin and SH3 domain containing 2a, transcript variant X11
sorbin and SH3 domain-containing protein 2 isoform X7
sorbin and SH3 domain-containing protein 2 isoform X8
sorbin and SH3 domain-containing protein 2 isoform X10
coiled-coil domain-containing protein 110
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
lecithin retinol acyltransferase, transcript variant X3
lecithin retinol acyltransferase isoform X3
lecithin retinol acyltransferase, transcript variant X2
lecithin retinol acyltransferase, transcript variant X1
uncharacterized protein LOC112231812 isoform X2
fibrinogen gamma chain, transcript variant X1
fibrinogen gamma chain, transcript variant X2
pleiotropic regulator 1-like, transcript variant X1
pleiotropic regulator 1-like, transcript variant X2
uncharacterized protein LOC112231812 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase TRIM39
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
thioredoxin-related transmembrane protein 2-B
large neutral amino acids transporter small subunit 3-like, transcript variant X2
large neutral amino acids transporter small subunit 3-like, transcript variant X1
large neutral amino acids transporter small subunit 3-like
sarcoplasmic/endoplasmic reticulum calcium ATPase 2
structure specific recognition protein 1b, transcript variant X2
structure specific recognition protein 1b, transcript variant X4
structure specific recognition protein 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
structure specific recognition protein 1b, transcript variant X1
structure specific recognition protein 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase core subunit S8a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LOW QUALITY PROTEIN: lysine-specific demethylase 2A
T cell immune regulator 1, ATPase H+ transporting V0 subunit a3a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
transmembrane protein 176, transcript variant X1
transmembrane protein 176, transcript variant X2
uncharacterized protein LOC571915 homolog, transcript variant X2
uncharacterized protein LOC571915 homolog, transcript variant X1
vacuolar protein sorting-associated protein 37C, transcript variant X1
vacuolar protein sorting-associated protein 37C, transcript variant X2
vacuolar protein sorting-associated protein 37C, transcript variant X3
vacuolar protein sorting-associated protein 37C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 83% coverage of the annotated genomic feature by RNAseq alignments
DNA repair protein complementing XP-A cells homolog
sodium/potassium/calcium exchanger 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
clathrin light chain A, transcript variant X1
clathrin light chain A, transcript variant X2
clathrin light chain A, transcript variant X3
uncharacterized LOC121841809, transcript variant X3
uncharacterized LOC121841809, transcript variant X1
uncharacterized LOC121841809, transcript variant X2
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, transcript variant X2
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, transcript variant X3
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, transcript variant X1
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, transcript variant X4
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase isoform X1
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase isoform X2
bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
tudor domain-containing protein 7A-like, transcript variant X3
tudor domain-containing protein 7A-like, transcript variant X1
tudor domain-containing protein 7A-like, transcript variant X2
tudor domain-containing protein 7A-like isoform X2
tudor domain-containing protein 7A-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
serine peptidase inhibitor, Kazal type 4
beta-1,4-galactosyltransferase 1, transcript variant X1
beta-1,4-galactosyltransferase 1, transcript variant X2
beta-1,4-galactosyltransferase 1 isoform X1
beta-1,4-galactosyltransferase 1 isoform X2
phospholipid-transporting ATPase ABCA1, transcript variant X5
phospholipid-transporting ATPase ABCA1, transcript variant X4
phospholipid-transporting ATPase ABCA1, transcript variant X3
phospholipid-transporting ATPase ABCA1, transcript variant X1
phospholipid-transporting ATPase ABCA1, transcript variant X2
phospholipid-transporting ATPase ABCA1 isoform X4
phospholipid-transporting ATPase ABCA1 isoform X3
phospholipid-transporting ATPase ABCA1 isoform X2
phospholipid-transporting ATPase ABCA1 isoform X1
zinc finger protein 205-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
early growth response protein 1-like, transcript variant X1
early growth response protein 1-like isoform X1
gastrula zinc finger protein XlCGF26.1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
gastrula zinc finger protein XlCGF26.1-like, transcript variant X1
gastrula zinc finger protein XlCGF26.1-like
early growth response protein 1-like, transcript variant X2
early growth response protein 1-like isoform X2
zinc finger and BTB domain-containing protein 41-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 41-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 41-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
zinc finger protein 205-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
uncharacterized LOC121841779, transcript variant X1
uncharacterized LOC121841779, transcript variant X2
uncharacterized protein LOC121841779 isoform X2
uncharacterized protein LOC121841779 isoform X1
uncharacterized LOC121841779, transcript variant X3
uncharacterized protein LOC121841779 isoform X3
zinc finger protein 69 homolog, transcript variant X4
zinc finger protein 69 homolog, transcript variant X3
zinc finger protein 69 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
zinc finger protein 69 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
zinc finger protein 69 homolog isoform X1
zinc finger protein 69 homolog isoform X4
zinc finger protein 69 homolog isoform X3
zinc finger protein 69 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger protein 775-like, transcript variant X2
zinc finger protein 775-like, transcript variant X1
transcriptional regulator Kaiso-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transcriptional regulator Kaiso-like, transcript variant X1
transcriptional regulator Kaiso-like, transcript variant X2
uncharacterized protein LOC112231629 isoform X1
transcriptional regulator Kaiso-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
uncharacterized LOC112231968, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC112231968, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
uncharacterized protein LOC112231968 isoform X2
uncharacterized protein LOC112231968 isoform X1
uncharacterized LOC112231961, transcript variant X1
uncharacterized LOC112231961, transcript variant X2
uncharacterized protein LOC112231961 isoform X1
uncharacterized protein LOC112231961 isoform X2
uncharacterized LOC121841783, transcript variant X1
uncharacterized LOC121841783, transcript variant X2
uncharacterized protein LOC121841783 isoform X1
uncharacterized protein LOC121841783 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized protein LOC112231960 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized protein LOC121841778 isoform X1
zinc finger and SCAN domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and SCAN domain-containing protein 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
zinc finger protein 697-like, transcript variant X2
uncharacterized protein LOC112231882 isoform X2
zinc finger protein 697-like, transcript variant X1
zinc finger protein 566-like, transcript variant X2
zinc finger protein 566-like, transcript variant X3
zinc finger protein 566-like, transcript variant X1
gastrula zinc finger protein 5-1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
laminin subunit beta-1-like, transcript variant X1
laminin subunit beta-1-like, transcript variant X3
uncharacterized LOC121841796, transcript variant X1
uncharacterized LOC121841796, transcript variant X2
uncharacterized protein LOC121841796 isoform X1
uncharacterized protein LOC121841796 isoform X2
laminin subunit beta-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
zinc finger protein with KRAB and SCAN domains 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
neurotrophin receptor-interacting factor homolog, transcript variant X1
neurotrophin receptor-interacting factor homolog, transcript variant X2
neurotrophin receptor-interacting factor homolog isoform X1
neurotrophin receptor-interacting factor homolog isoform X2
zinc finger protein 624-like, transcript variant X2
zinc finger protein 624-like, transcript variant X4
zinc finger protein 624-like, transcript variant X1
zinc finger protein 624-like, transcript variant X3
uncharacterized protein LOC112231880 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 148-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 148-like, transcript variant X1
uncharacterized protein LOC112231886 isoform X1
zinc finger protein 148-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
zinc finger protein 583, transcript variant X2
zinc finger protein 583, transcript variant X4
zinc finger protein 583, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized protein LOC112231940 isoform X2
zinc finger protein 583, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
zinc finger protein 583, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
endothelial zinc finger protein induced by tumor necrosis factor alpha-like
zinc finger and SCAN domain-containing protein 12-like, transcript variant X3
zinc finger and SCAN domain-containing protein 12-like, transcript variant X2
zinc finger and SCAN domain-containing protein 12-like, transcript variant X1
zinc finger and SCAN domain-containing protein 12-like isoform X3
zinc finger and SCAN domain-containing protein 12-like isoform X2
zinc finger and SCAN domain-containing protein 12-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC112231612
zinc finger protein with KRAB and SCAN domains 8-like, transcript variant X1
zinc finger protein with KRAB and SCAN domains 8-like, transcript variant X2
zinc finger protein ZFAT-like isoform X1
zinc finger protein ZFAT-like isoform X2
zinc finger protein 629, transcript variant X1
zinc finger protein 629, transcript variant X2
oocyte zinc finger protein XlCOF29 isoform X2
hypermethylated in cancer 1 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
zinc finger protein 34-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized protein LOC112231909 isoform X2
zinc finger protein 34-like, transcript variant X1
protein krueppel-like, transcript variant X1
protein krueppel-like, transcript variant X2
neurotrophin receptor-interacting factor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
zinc finger protein with KRAB and SCAN domains 8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
zinc finger protein with KRAB and SCAN domains 8-like isoform X3
transcription factor E4F1-like, transcript variant X2
transcription factor E4F1-like isoform X2
transcription factor E4F1-like, transcript variant X1
uncharacterized protein LOC121841781 isoform X1
zinc finger protein 16-like, transcript variant X2
zinc finger protein 16-like, transcript variant X1
zinc finger protein with KRAB and SCAN domains 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
zinc finger protein with KRAB and SCAN domains 8, transcript variant X1
zinc finger protein with KRAB and SCAN domains 8 isoform X1
uncharacterized protein LOC112231901 isoform X2
Krueppel-like factor 9, transcript variant X2
Krueppel-like factor 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc finger protein 507-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger protein 507-like, transcript variant X1
uncharacterized protein LOC112231910 isoform X1
zinc finger protein 184-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 184-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
zinc finger protein 184-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gastrula zinc finger protein XlCGF48.2-like isoform X1
gastrula zinc finger protein XlCGF48.2-like isoform X2
zinc finger and BTB domain-containing protein 18, transcript variant X2
zinc finger and BTB domain-containing protein 18, transcript variant X1
zinc finger and BTB domain-containing protein 18 isoform X2
uncharacterized protein LOC112231617 isoform X1
zinc finger and BTB domain-containing protein 18, transcript variant X3
zinc finger and BTB domain-containing protein 18 isoform X3
uncharacterized LOC112231922, transcript variant X1
uncharacterized LOC112231922, transcript variant X2
uncharacterized LOC112231912, transcript variant X2
uncharacterized LOC112231912, transcript variant X3
uncharacterized LOC112231912, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized protein LOC112231912 isoform X2
uncharacterized protein LOC112231912 isoform X3
uncharacterized protein LOC112231912 isoform X5
uncharacterized LOC112231912, transcript variant X1
uncharacterized LOC112231912, transcript variant X4
uncharacterized protein LOC112231912 isoform X1
uncharacterized protein LOC112231912 isoform X4
zinc finger protein 354C-like, transcript variant X2
zinc finger protein 354C-like isoform X2
zinc finger protein 354C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
zinc finger protein 583, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
zinc finger protein 583, transcript variant X5
zinc finger protein 3-like, transcript variant X1
zinc finger protein 3-like, transcript variant X2
oocyte zinc finger protein XlCOF7.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neurotrophin receptor-interacting factor homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized protein LOC112231927 isoform X2
neurotrophin receptor-interacting factor homolog isoform X4
neurotrophin receptor-interacting factor homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger protein 629-like, transcript variant X2
zinc finger protein 629-like, transcript variant X1
transcription factor Sp8, transcript variant X2
transcription factor Sp8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein WWC2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
protein WWC2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
protein WWC2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
protein WWC2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
deoxycytidylate deaminase-like, transcript variant X2
deoxycytidylate deaminase-like, transcript variant X1
deoxycytidylate deaminase-like isoform X2
deoxycytidylate deaminase-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
LOW QUALITY PROTEIN: vegetative cell wall protein gp1-like
vascular endothelial growth factor C, transcript variant X1
vascular endothelial growth factor C isoform X1
vascular endothelial growth factor C, transcript variant X2
vascular endothelial growth factor C isoform X2
ankyrin repeat and SOCS box containing 5b, transcript variant X1
ankyrin repeat and SOCS box protein 5 isoform X1
ankyrin repeat and SOCS box containing 5b, transcript variant X2
ankyrin repeat and SOCS box protein 5 isoform X2
ankyrin repeat and SOCS box containing 5b, transcript variant X3
ankyrin repeat and SOCS box protein 5 isoform X3
WD repeat-containing protein 17, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WD repeat-containing protein 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WD repeat-containing protein 17, transcript variant X1
WD repeat-containing protein 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WD repeat-containing protein 17 isoform X2
WD repeat-containing protein 17 isoform X3
WD repeat-containing protein 17 isoform X1
WD repeat-containing protein 17 isoform X4
neuronal membrane glycoprotein M6-a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
neuronal membrane glycoprotein M6-a, transcript variant X1
neuronal membrane glycoprotein M6-a isoform X1
neuronal membrane glycoprotein M6-a isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
centrosomal protein of 44 kDa, transcript variant X3
centrosomal protein of 44 kDa, transcript variant X4
centrosomal protein of 44 kDa, transcript variant X2
centrosomal protein of 44 kDa, transcript variant X1
N-acetylgalactosaminyltransferase 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase-like 6
transmembrane protein 154, transcript variant X4
transmembrane protein 154, transcript variant X3
transmembrane protein 154, transcript variant X2
transmembrane protein 154, transcript variant X1
F-box/WD repeat-containing protein 7, transcript variant X1
F-box/WD repeat-containing protein 7 isoform X1
F-box/WD repeat-containing protein 7, transcript variant X2
F-box/WD repeat-containing protein 7 isoform X2
glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial
FHF complex subunit HOOK interacting protein 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
FHF complex subunit HOOK interacting protein 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
FHF complex subunit HOOK interacting protein 1A
SH3 domain-containing protein 19, transcript variant X2
SH3 domain-containing protein 19, transcript variant X1
SH3 domain-containing protein 19, transcript variant X4
SH3 domain-containing protein 19, transcript variant X3
SH3 domain-containing protein 19 isoform X1
SH3 domain-containing protein 19 isoform X3
SH3 domain-containing protein 19 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00560
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X1
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X3
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X2
lipopolysaccharide-responsive and beige-like anchor protein, transcript variant X4
lipopolysaccharide-responsive and beige-like anchor protein isoform X1
lipopolysaccharide-responsive and beige-like anchor protein isoform X4
lipopolysaccharide-responsive and beige-like anchor protein isoform X3
lipopolysaccharide-responsive and beige-like anchor protein isoform X2
serine/threonine-protein kinase DCLK2-like, transcript variant X1
serine/threonine-protein kinase DCLK2-like, transcript variant X2
serine/threonine-protein kinase DCLK2-like isoform X2
serine/threonine-protein kinase DCLK2-like isoform X1
serine/threonine-protein kinase DCLK2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein kinase DCLK2-like, transcript variant X5
serine/threonine-protein kinase DCLK2-like isoform X3
serine/threonine-protein kinase DCLK2-like, transcript variant X4
serine/threonine-protein kinase DCLK2-like isoform X4
mineralocorticoid receptor-like, transcript variant X1
mineralocorticoid receptor-like, transcript variant X3
mineralocorticoid receptor-like, transcript variant X2
mineralocorticoid receptor-like isoform X1
mineralocorticoid receptor-like isoform X2
rho GTPase-activating protein 10, transcript variant X1
rho GTPase-activating protein 10 isoform X1
rho GTPase-activating protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
rho GTPase-activating protein 10 isoform X2
protein arginine N-methyltransferase 9, transcript variant X2
protein arginine N-methyltransferase 9, transcript variant X1
protein arginine N-methyltransferase 9 isoform X1
protein arginine N-methyltransferase 9, transcript variant X3
protein arginine N-methyltransferase 9 isoform X2
endothelin receptor type B-like, transcript variant X2
endothelin receptor type B-like, transcript variant X1
endothelin receptor type B-like isoform X1
endothelin receptor type B-like isoform X2
POU domain, class 4, transcription factor 2-like
U6 snRNA-associated Sm-like protein LSm6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 827
methylmalonic aciduria type A homolog, mitochondrial
mothers against decapentaplegic homolog 1-like, transcript variant X3
mothers against decapentaplegic homolog 1-like, transcript variant X2
mothers against decapentaplegic homolog 1-like, transcript variant X1
mothers against decapentaplegic homolog 1-like isoform X3
mothers against decapentaplegic homolog 1-like isoform X2
mothers against decapentaplegic homolog 1-like isoform X1
ATP-binding cassette sub-family E member 1
hedgehog-interacting protein-like, transcript variant X1
hedgehog-interacting protein-like, transcript variant X3
hedgehog-interacting protein-like, transcript variant X2
uncharacterized si:dkey-27h10.2, transcript variant X4
uncharacterized si:dkey-27h10.2, transcript variant X3
uncharacterized si:dkey-27h10.2, transcript variant X1
uncharacterized si:dkey-27h10.2, transcript variant X2
uncharacterized si:dkey-27h10.2, transcript variant X6
uncharacterized si:dkey-27h10.2, transcript variant X5
uncharacterized protein si:dkey-27h10.2 isoform X1
uncharacterized protein si:dkey-27h10.2 isoform X4
uncharacterized protein si:dkey-27h10.2 isoform X2
uncharacterized protein si:dkey-27h10.2 isoform X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5-like
ubiquitin carboxyl-terminal hydrolase 38
GRB2-associated-binding protein 1, transcript variant X4
GRB2-associated-binding protein 1, transcript variant X6
GRB2-associated-binding protein 1, transcript variant X5
GRB2-associated-binding protein 1, transcript variant X2
GRB2-associated-binding protein 1, transcript variant X8
GRB2-associated-binding protein 1, transcript variant X3
GRB2-associated-binding protein 1, transcript variant X1
GRB2-associated-binding protein 1, transcript variant X7
GRB2-associated-binding protein 1, transcript variant X9
GRB2-associated-binding protein 1 isoform X1
GRB2-associated-binding protein 1 isoform X2
GRB2-associated-binding protein 1 isoform X3
GRB2-associated-binding protein 1 isoform X5
GRB2-associated-binding protein 1 isoform X4
GRB2-associated-binding protein 1 isoform X6
GRB2-associated-binding protein 1, transcript variant X12
GRB2-associated-binding protein 1, transcript variant X13
GRB2-associated-binding protein 1, transcript variant X11
GRB2-associated-binding protein 1, transcript variant X15
GRB2-associated-binding protein 1, transcript variant X14
GRB2-associated-binding protein 1, transcript variant X10
GRB2-associated-binding protein 1 isoform X7
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X1
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X2
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X3
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X12
type II inositol 3,4-bisphosphate 4-phosphatase isoform X3
type II inositol 3,4-bisphosphate 4-phosphatase isoform X10
type II inositol 3,4-bisphosphate 4-phosphatase isoform X1
type II inositol 3,4-bisphosphate 4-phosphatase isoform X2
type II inositol 3,4-bisphosphate 4-phosphatase isoform X9
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X4
type II inositol 3,4-bisphosphate 4-phosphatase isoform X4
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X6
type II inositol 3,4-bisphosphate 4-phosphatase isoform X6
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X7
type II inositol 3,4-bisphosphate 4-phosphatase isoform X7
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X10
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X5
type II inositol 3,4-bisphosphate 4-phosphatase isoform X5
type II inositol 3,4-bisphosphate 4-phosphatase, transcript variant X9
type II inositol 3,4-bisphosphate 4-phosphatase isoform X8
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 3 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 3 codons; deleted 2 bases in 2 codons; substituted 5 bases at 5 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: TBC1 domain family member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns